These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36043376)

  • 1. Digital Gait Biomarkers Allow to Capture 1-Year Longitudinal Change in Spinocerebellar Ataxia Type 3.
    Ilg W; Müller B; Faber J; van Gaalen J; Hengel H; Vogt IR; Hennes G; van de Warrenburg B; Klockgether T; Schöls L; Synofzik M;
    Mov Disord; 2022 Nov; 37(11):2295-2301. PubMed ID: 36043376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital Gait Measures Capture 1-Year Progression in Early-Stage Spinocerebellar Ataxia Type 2.
    Seemann J; Daghsen L; Cazier M; Lamy JC; Welter ML; Giese MA; Synofzik M; Durr A; Ilg W; Coarelli G
    Mov Disord; 2024 May; 39(5):788-797. PubMed ID: 38419144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-Life Turning Movements Capture Subtle Longitudinal and Preataxic Changes in Cerebellar Ataxia.
    Thierfelder A; Seemann J; John N; Harmuth F; Giese M; Schüle R; Schöls L; Timmann D; Synofzik M; Ilg W
    Mov Disord; 2022 May; 37(5):1047-1058. PubMed ID: 35067979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of Clinical and Eye Movement Markers in Preataxic Carriers of Machado-Joseph Disease.
    de Oliveira CM; Leotti VB; Cappelli AH; Rocha AG; Ecco G; Bolzan G; Kersting N; Saraiva-Pereira ML; Jardim LB
    Mov Disord; 2023 Jan; 38(1):26-34. PubMed ID: 36129443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Clinical and Blood Biomarkers in Patients With Preataxic and Early-Stage Disease Spinocerebellar Ataxia 1 and 3.
    Tezenas du Montcel S; Petit E; Olubajo T; Faber J; Lallemant-Dudek P; Bushara K; Perlman S; Subramony SH; Morgan D; Jackman B; Figueroa KP; Pulst SM; Fauret-Amsellem AL; Dufke C; Paulson HL; Öz G; Klockgether T; Durr A; Ashizawa T;
    Neurology; 2023 Apr; 100(17):e1836-e1848. PubMed ID: 36797067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive-affective manifestations since premanifest phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
    Bolzan G; Müller Eyng ME; Leotti VB; Saraiva-Pereira ML; Jardim LB
    Cortex; 2024 Feb; 171():370-382. PubMed ID: 38091940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
    Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
    Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3.
    Faber J; Schaprian T; Berkan K; Reetz K; França MC; de Rezende TJR; Hong J; Liao W; van de Warrenburg B; van Gaalen J; Durr A; Mochel F; Giunti P; Garcia-Moreno H; Schoels L; Hengel H; Synofzik M; Bender B; Oz G; Joers J; de Vries JJ; Kang JS; Timmann-Braun D; Jacobi H; Infante J; Joules R; Romanzetti S; Diedrichsen J; Schmid M; Wolz R; Klockgether T
    Mov Disord; 2021 Oct; 36(10):2273-2281. PubMed ID: 33951232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3.
    Maas RPPWM; Teerenstra S; Lima M; Pires P; Pereira de Almeida L; van Gaalen J; Timmann D; Infante J; Onyike C; Bushara K; Jacobi H; Reetz K; Santana MM; Afonso Ribeiro J; Hübener-Schmid J; de Vries JJ; Synofzik M; Schöls L; Garcia-Moreno H; Giunti P; Faber J; Klockgether T; van de Warrenburg BPC
    Mov Disord; 2022 Sep; 37(9):1850-1860. PubMed ID: 35808813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodromal Spinocerebellar Ataxia Type 2 Subjects Have Quantifiable Gait and Postural Sway Deficits.
    Velázquez-Pérez L; Rodriguez-Labrada R; González-Garcés Y; Arrufat-Pie E; Torres-Vega R; Medrano-Montero J; Ramirez-Bautista B; Vazquez-Mojena Y; Auburger G; Horak F; Ziemann U; Gomez CM
    Mov Disord; 2021 Feb; 36(2):471-480. PubMed ID: 33107647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Dynamics of the Scale for the Assessment and Rating of Ataxia in Spinocerebellar Ataxias.
    Moulaire P; Poulet PE; Petit E; Klockgether T; Durr A; Ashisawa T; Tezenas du Montcel S;
    Mov Disord; 2023 Jan; 38(1):35-44. PubMed ID: 36273394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of gait and balance impairment in people with spinocerebellar ataxia using wearable sensors.
    Zhou H; Nguyen H; Enriquez A; Morsy L; Curtis M; Piser T; Kenney C; Stephen CD; Gupta AS; Schmahmann JD; Vaziri A
    Neurol Sci; 2022 Apr; 43(4):2589-2599. PubMed ID: 34664180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual changes in preclinical spinocerebellar ataxia identified via increased motor complexity.
    Ilg W; Fleszar Z; Schatton C; Hengel H; Harmuth F; Bauer P; Timmann D; Giese M; Schöls L; Synofzik M
    Mov Disord; 2016 Dec; 31(12):1891-1900. PubMed ID: 27782309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The longitudinal progression of MRI changes in pre-ataxic carriers of SCA3/MJD.
    de Oliveira CM; Leotti VB; Polita S; Anes M; Cappelli AH; Rocha AG; Ecco G; Bolzan G; Kersting N; Duarte JA; Saraiva-Pereira ML; Junior MCF; Rezende TJR; Jardim LB
    J Neurol; 2023 Sep; 270(9):4276-4287. PubMed ID: 37193796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A standardised protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxia.
    Santana MM; Gaspar LS; Pinto MM; Silva P; Adão D; Pereira D; Ribeiro JA; Cunha I; Huebener-Schmid J; Raposo M; Ferreira AF; Faber J; Kuhs S; Garcia-Moreno H; Reetz K; Thieme A; Infante J; van de Warrenburg BPC; Giunti P; Riess O; Schöls L; Lima M; Klockgether T; Januário C; de Almeida LP;
    Neuropathol Appl Neurobiol; 2023 Apr; 49(2):e12892. PubMed ID: 36798010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of Gait Ataxia in Patients with Degenerative Cerebellar Disorders: a 4-Year Follow-Up Study.
    Serrao M; Chini G; Casali C; Conte C; Rinaldi M; Ranavolo A; Marcotulli C; Leonardi L; Fragiotta G; Bini F; Coppola G; Pierelli F
    Cerebellum; 2017 Jun; 16(3):629-637. PubMed ID: 27924492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial.
    Saute JA; Rieder CR; Castilhos RM; Monte TL; Schumacher-Schuh AF; Donis KC; D'Ávila R; Souza GN; Russo AD; Furtado GV; Gheno TC; Souza DO; Saraiva-Pereira ML; Portela LV; Camey S; Torman VB; Jardim LB
    J Neurol Sci; 2015 Nov; 358(1-2):72-6. PubMed ID: 26297649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-life gait assessment in degenerative cerebellar ataxia: Toward ecologically valid biomarkers.
    Ilg W; Seemann J; Giese M; Traschütz A; Schöls L; Timmann D; Synofzik M
    Neurology; 2020 Sep; 95(9):e1199-e1210. PubMed ID: 32611635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.